Physician profile
Masood Hashmi
NPI 1831100833
$741.31
in general payments reported to CMS, 2019-2025
24 companies · $88.10 in 2025
The $88.10 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $80.87 · 2024: $17.69 · 2025: $88.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $88.10 | 2025 | |
| Biogen, INC. | $59.84 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $42.80 | 2020 | |
| Grifols USA, LLC | $41.26 | 2019 | |
| Lilly USA, LLC | $40.61 | 2019 | |
| Amgen INC. | $40.29 | 2019 | |
| Allergan, INC. | $39.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.91 | 2019 | |
| Neurocrine Biosciences, INC. | $33.46 | 2019 | |
| Mdd US Operations, LLC | $32.25 | 2019 | |
| Genzyme Corporation | $31.79 | 2019 | |
| Portola Pharmaceuticals, LLC | $29.29 | 2019 | |
| Ucb, INC. | $28.81 | 2019 | |
| Acadia Pharmaceuticals INC | $23.29 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.31 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $19.86 | 2019 | |
| Acorda Therapeutics, INC | $19.02 | 2019 | |
| Ge Healthcare | $18.63 | 2019 | |
| Supernus Pharmaceuticals, INC. | $18.61 | 2019 | |
| Emd Serono, INC. | $18.30 | 2019 | |
| Reel Surgical, INC. | $17.69 | 2024 | |
| Upsher-Smith Laboratories LLC | $15.60 | 2020 | |
| Bausch Health US, LLC | $12.97 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masood Hashmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.